New shot aims to fight fat in early human test
NCT ID NCT06471530
Summary
This early-stage study tested a new injectable drug, TE-8105, for weight loss in overweight or obese adults without diabetes. The main goals were to check if the drug is safe, how the body handles it, and if it affects body weight. Researchers gave single and multiple doses to 38 participants to gather this initial information.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CMAX Clinical Research
Adelaide, South Australia, 5000, Australia
Conditions
Explore the condition pages connected to this study.